证券记录 · 已归档季度
WST
West Pharmaceutical Services, Inc. · Healthcare · Medical - Instruments & Supplies
21被追踪持有人
-1Δ持有人
26.99M持有股份
$7.08B报告持仓市值
+0新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -4.5% ·
股份流向 +2.6% ·
净新建仓位 -9.5%
· 公式
集中增持：持股数量上升，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 175.10K | $64.20M | n/a | n/a |
| Q2 2026 | 160 | +3 | 50.04M | $17.95B | +8 | −6 |
| Q1 2026 | 161 | -2 | 49.75M | $12.46B | +4 | −7 |
| Q4 2025 | 162 | +3 | 53.70M | $14.74B | +5 | −1 |
| Q3 2025 | 21 | -1 | 26.99M | $7.08B | n/a | −2 |
| Q2 2025 | 20 | 0 | 24.84M | $5.43B | +1 | −1 |
| Q1 2025 | 17 | +2 | 8.37M | $1.87B | +2 | n/a |
| Q4 2024 | 15 | +2 | 8.55M | $2.80B | +2 | n/a |
| Q3 2024 | 12 | -1 | 4.43M | $1.33B | n/a | −1 |
| Q2 2024 | 13 | n/a | 5.33M | $1.75B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 9.70M | +4.2% | $2.55B | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (被动) | 6.46M | -2.3% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ ×21 |
| 3 | State Street Global Advisors ✦ (被动) | 3.21M | -1.9% | $841.53M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 1.86M | +1.3% | $485.20M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Morgan Stanley ✦ | 1.48M | n/a | $387.89M | 0.0% | n/c | 1 | SEC ↗ ×19 |
| 6 | Citadel Advisors ✦ | 727.54K | +464.9% | $190.85M | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Point72 Asset Management ✦ | 659.25K | +93.9% | $172.94M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 545.88K | +420.1% | $142.95M | 0.1% | ▲ Add | 6 | SEC ↗ ×8 |
| 9 | JPMorgan Chase ✦ | 473.93K | n/a | $124.33M | 0.0% | n/c | 1 | SEC ↗ ×28 |
| 10 | Gates Foundation Trust ✦ | 444.50K | 0.0% | $116.61M | 0.3% | Held | 3 | SEC ↗ |
| 11 | Goldman Sachs Group ✦ | 418.08K | n/a | $109.67M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 12 | Millennium Management ✦ | 312.99K | -32.8% | $82.11M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 220.96K | +71.2% | $57.97M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 127.15K | -55.3% | $33.35M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 114.55K | -2.6% | $30.05M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 16 | Two Sigma Investments ✦ | 101.20K | -82.7% | $26.55M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 55.51K | -15.7% | $14.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Fidelity (FMR) ✦ | 44.36K | -57.7% | $11.64M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 19 | Fisher Asset Management ✦ | 21.95K | -9.8% | $5.76M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Wellington Management ✦ | 14.62K | +5.9% | $3.84M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 21 | Marshall Wace ✦ | 800 | -98.7% | $209,864 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $200.81M | 曾为 0.0% |
| Renaissance Technologies | $5.32M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 749 持有人, 70.07M 股份, $16.37B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 15
Favorite Annette F
Officer · 2.52K 股 · $921,260
Sep 14
Favorite Annette F
Officer · 2.50K 股 · $887,500
Sep 11
Favorite Annette F
Officer · 2.50K 股 · $862,500
Sep 08
Favorite Annette F
Officer · 2.82K 股 · $960,062
Sep 08
Favorite Annette F
Officer · 2.82K 股 · $960,403
Sep 08
Favorite Annette F
Officer · 2.50K 股 · $852,025
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 06
SC 13G: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据